Results 31 to 40 of about 86,432 (312)

Implantable Cardioverter Defibrillator

Majalah Kardiologi Indonesia, 2013
Ide penggunaan Implantable Cardioverter Defibrillator (ICD) untuk pencegahan kematian jantung mendadak pertama kali dicetuskan oleh Dr. Michel Mirowski pada tahun 1970. Sejak itu ICD berkembang dari sebuah prototipe yang dicoba pada binatang menjadi alat
Dicky Armen Hanafy
doaj   +1 more source

Implantable cardioverter defibrillator specific rehabilitation improves health cost outcomes:Findings from the COPE-ICD randomized controlled trial [PDF]

, 2015
Objective: The Copenhagen Outpatient ProgrammE - implantable cardioverter defibrillator (COPE-ICD) trial included patients with implantable cardioverter defibrillators in a randomized controlled trial of rehabilitation.
Kikkenborg Berg, Selina, Koch, Mette Bjerrum, Pedersen, Preben U, Svendsen, Jesper Hastrup, Thygesen, Lau Caspar, Vinggaard Christensen, Anne, Zwisler, Ann-Dorthe   +6 more
core   +1 more source

Prospective blinded evaluation of a novel sensing methodology designed to reduce inappropriate shocks by the subcutaneous implantable cardioverter-defibrillator.

Heart Rhythm, 2018
BACKGROUND Most inappropriate shocks from the subcutaneous implantable cardioverter-defibrillator (S-ICD) are caused by cardiac oversensing. A novel sensing methodology, SMART Pass (SP; Boston Scientific Corporation, Natick, MA), aims to reduce cardiac ...
D. Theuns, T. Brouwer, P. Jones, V. Allavatam, S. Donnelley, A. Auricchio, R. Knops, M. Burke   +7 more
semanticscholar   +1 more source

Incidence and Costs Related to Lead Damage Occurring Within the First Year After a Cardiac Implantable Electronic Device Replacement Procedure

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundInadvertent damage to leads for transvenous pacemakers, implantable cardioverter‐defibrillators, and cardiac resynchronization therapy defibrillators is an important complication associated with generator‐replacement procedures.
Christine I. Nichols, Joshua G. Vose, Suneet Mittal   +2 more
doaj   +1 more source

Use of Nonrecommended Drugs in Patients With Brugada Syndrome: A Danish Nationwide Cohort Study

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background Patients with Brugada syndrome (BrS) are recommended to avoid drugs that may increase their risk of arrhythmic events. We examined treatment with such drugs in patients with BrS after their diagnosis.
Camilla H. B. Jespersen, Johanna Krøll, Priya Bhardwaj, Carl Johann Hansen, Jesper Svane, Bo G. Winkel, Christian Jøns, Peter Karl Jacobsen, Jens Haarbo, Jens Cosedis Nielsen, Jens Brock Johansen, Berit T. Philbert, Sam Riahi, Christian Torp‐Pedersen, Lars Køber, Jacob Tfelt‐Hansen, Peter E. Weeke   +16 more
doaj   +1 more source

Managing patients with ICD shocks and programming tachycardia therapies during acute heart failure syndromes [PDF]

, 2011
We review the pharmacologic, interventional and device programming treatment options for patients with implantable cardioverter-defibrillators who present with acute heart failure and implantable cardioverter-defibrillator ...
Jason Bradfield, Roderick Tung, Noel G. Boyle, Kalyanam Shivkumar   +3 more
core   +1 more source

Subcutaneous implantable cardioverter-defibrillator Post-Approval Study: Clinical characteristics and perioperative results.

Heart Rhythm, 2017
BACKGROUND The subcutaneous implantable cardioverter-defibrillator (S-ICD) was developed to reduce short- and long-term complications associated with transvenous ICD leads.
M. Gold, Johan D. Aasbo, M. El-Chami, M. Niebauer, J. Herre, J. Prutkin, B. Knight, S. Kutalek, K. Hsu, R. Weiss, E. Bass, M. Husby, T. Stivland, M. Burke   +13 more
semanticscholar   +1 more source

New horizon for infection prevention technology and implantable device

Journal of Arrhythmia, 2016
There has been a significant increase in the number of patients receiving cardiovascular implantable electronic devices (CIED) over the last two decades.
Yusuke Kondo, MD, PhD, Marehiko Ueda, MD, PhD, Yoshio Kobayashi, MD, PhD, Joerg O. Schwab, MD, PhD   +3 more
doaj   +1 more source

Arrhythmic Risk Profile and Outcomes of Patients Undergoing Cardiac Sympathetic Denervation for Recurrent Monomorphic Ventricular Tachycardia After Ablation

Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Cardiac sympathetic denervation (CSD) has been used as a bailout strategy for refractory ventricular tachycardia (VT). Risk of VT recurrence in patients with scar‐related monomorphic VT referred for CSD and the extent to which CSD can modify ...
Veronica Dusi, Jeffrey Gornbein, Duc H. Do, Julie M. Sorg, Houman Khakpour, Yuliya Krokhaleva, Olujimi A. Ajijola, Carlos Macias, Jason S. Bradfield, Eric Buch, Osamu A. Fujimura, Noel G. Boyle, Jane Yanagawa, Jay M. Lee, Kalyanam Shivkumar, Marmar Vaseghi   +15 more
doaj   +1 more source

Risk Stratification in Post-MI Patients Based on Left Ventricular Ejection Fraction and Heart-Rate Turbulence [PDF]

, 2003
Objectives: Development of risk stratification criteria for predicting mortality in post-infarction patients taking into account LVEF and heart-rate turbulence (HRT).
Barthel, Petra, Bigger Jr., J. Thomas, Malik, M., Rolnitzky, Linda, Schmidt, Georg, Schneider, Raphael, Ulm, Kurt   +6 more
core   +1 more source